As a result of the partnership, clinicians using Epic will be able to order Foundation Medicine's genomic profiling tests directly from the EHR and view results in the system, providing them with clinical decision support.
Merck is discontinuing the development of two Covid-19 vaccines after phase 1 data showed that immune responses fell short of expectations. Instead, the drugmaker plans to focus on two potential Covid-19 treatments.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!